NY S 10260

in committee

Adds CLN2, MPS IVA, MPS VI, MPS VII and Fabry diseases to the newborn screening panel for New York state

New York · 2025-2026 Regular Session · upper

Quick answers

Did NY S 10260 pass?

Not yet. NY S 10260 is in committee as of 2026-05-08 and has not come to a final vote. Latest recorded action (2026-05-08): REFERRED TO HEALTH

What is NY S 10260 about?

Adds CLN2, MPS IVA, MPS VI, MPS VII and Fabry diseases to the newborn screening panel for New York state; requires tests be made available within twelve months.

Who sponsors NY S 10260?

Lea Webb is the primary sponsor of NY S 10260, joined by 2 cosponsors.

Description

Adds CLN2, MPS IVA, MPS VI, MPS VII and Fabry diseases to the newborn screening panel for New York state; requires tests be made available within twelve months.

Introduced: —
Latest action: 2026-05-08 — REFERRED TO HEALTH
Bill type: bill
Last updated: —

Committees

Not provided by source.

Action timeline

2026-05-08
REFERRED TO HEALTH
referral-committee

Versions

S10260Compare

Documents

Votes

Not provided by source.

Related bills

Companion bill: A 10521

Official source

https://legislation.nysenate.gov/api/3/bills/2025-2026/S10260?summary=&detail=

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z

Inspect retained evidence for changes recorded after evidence tracking began:

Source and document changes Status and relationship changes

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=S 10260. See the API docs or the MCP server for AI assistants.

Known limitations

Sponsor party and chamber affiliation are not yet captured by this API.
Committee referrals are not yet captured.

See the methodology page for data sources and limitations.